PURPOSE: The aim of this pilot study was to compare the effect of heparin anticoagulation with and without iloprost administration during continuous renal replacement therapy (CRRT) in critically ill patients. MATERIAL AND METHODS: In a prospective, randomized, controlled pilot study at an intensive care unit at a university hospital, 20 patients requiring CRRT were investigated. Patients were allocated into two groups: group 1, the heparin group; and group 2, the heparin plus 1 ng/kg/min iloprost. In both groups, activated partial thromboplastin time (aPTT) was adjusted to 40-50 sec. Observation time was a maximum of 7 days. RESULTS: Median filter run time was significantly prolonged by iloprost administration to a median of 14 h (13-26 h) compared to 10 h (4-12 h) in the heparin group (p = 0.004). A decrease in platelet count was attenuated by iloprost administration (p = 0.012). There were no bleeding complications in either group. Hemofiltration efficiency did not differ significantly between the groups. CONCLUSION: Additional administration of iloprost prolonged the filter run time of continuous veno-venous hemofiltration (CVVH) in this setting and attenuated the fall in platelet count during CRRT.
Iloprost for additional anticoagulation in continuous renal replacement therapy - a pilot study. Publishing Authors By Initials
Iloprost for additional anticoagulation in continuous renal replacement therapy - a pilot study. Journal Published:
PUBLICATION TYPE: Journal Article
Journal: Renal failure
VOLUME: 29
Page Numbers: 271-7
Journal Abbreviation:
ISSN: 0886-022X
DAY: 14
MONTH: 05
YEAR: 2007
Iloprost for additional anticoagulation in continuous renal replacement therapy - a pilot study. Information
Number of References:
LANGUAGE: eng
NlmUniqueID: 8701128
Iloprost for additional anticoagulation in continuous renal replacement therapy - a pilot study. Keywords Mesh Terms:
KEYWORDS:
MESH TERMS:
Chemical & Substance for Abstract: Iloprost for additional anticoagulation in continuous renal replacement therapy - a pilot study. Information
Substance Name:
Registry Number:
Grant and Affiliation Information for Iloprost for additional anticoagulation in continuous renal replacement therapy - a pilot study.
AFFILIATION: Department of Anesthesiology and Intensive Care Medicine, Campus Charité Mitte and Campus Charité Virchow-Klinikum, Charité-University Medicine, Berlin, Germany. juergen.birnbaum@charite.de
Country: United States
AGENCY:
GRANT:
ACRONYM:
MEDLINETA: Ren Fail
REFSOURCE:
DATABASENAME:
ACCESSION NUMBER:
Number Hits: 0
Iloprost for additional anticoagulation in continuous renal replacement therapy - a pilot study Related Publications